Holen Sie sich die Stockscreener-App
134.46
5.54%
7.06
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected MultiomicsPR Newswire APAC - PR Newswire Asia
Illumina: Competitive Pressures Mounting but 2026 Revenue Targets Still Intact, Justifying a Hold Rating - TipRanks
Florida lab uses genome sequencing to diagnose children with rare diseases - Stock Titan
Primecap Management Co. CA Sells 73,220 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. Unveils Revolutionary Genomic Advancements - Devdiscourse
What a $75 Million Exit From MDU Might Signal Amid a 24% One-Year Rally - The Motley Fool
The next generation is shaping the future of rare diseases - Illumina
Evercore ISI reiterates Illumina stock rating on competitive positioning By Investing.com - Investing.com India
Canaccord reiterates Illumina stock Hold rating after Roche pricing By Investing.com - Investing.com Canada
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Present - PharmiWeb.com
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics - PR Newswire
Vestmark Advisory Solutions Inc. Sells 22,703 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Bought by North Star Asset Management Inc. - MarketBeat
Illumina Genome Push Raises Questions On Growth, Adoption And Valuation - simplywall.st
Illumina launches TruPath Genome, setting a new standard in genomic insight - Investing News Network
Illumina Launches TruPath Genome Workflow Solution - marketscreener.com
Illumina's TruPath Genome offers rapid whole genome testing for rare disease - Stock Titan
NovaSeq X Series innovation roadmap - Illumina
Next Generation Sequencing Market Competitive Landscape - GlobeNewswire
Illumina, Inc. (NASDAQ:ILMN) Receives Average Rating of "Hold" from Analysts - MarketBeat
Illumina unveils NovaSeq X upgrades with 40% output increase - Investing.com Australia
Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews
Faster DNA decoding: Illumina’s NovaSeq X gets 40% more data, higher accuracy - Stock Titan
Illumina Beat Q4 Earnings and Closed a $350M Acquisition. Here’s What Investors Need to Know - TIKR.com
Why Illumina Inc. stock is a must watch in 20252025 Support & Resistance & Free Verified High Yield Trade Plans - mfd.ru
Illumina, Inc. $ILMN Shares Sold by Vanguard Group Inc. - MarketBeat
Jupiter Asset Management Ltd. Makes New $16.69 Million Investment in Illumina, Inc. $ILMN - MarketBeat
This once-hot cancer-detection company’s stock got cut in half after a failed trial - MarketWatch
Illumina SVP Leckman sells $275k in stock By Investing.com - Investing.com South Africa
Illumina SVP Leckman sells $275k in stock - Investing.com Australia
Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance
We Think That There Are Some Issues For Illumina (NASDAQ:ILMN) Beyond Its Promising Earnings - 富途牛牛
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com
DNA Sequencing Market Is Booming So Rapidly by 2033 | Thermo Fisher Scientific, Inc., Illumina - openPR.com
Illumina Single Cell RNA Seq helps advance avian conservation - Illumina
Buyout Rumor: What is the Moat Score of Illumina IncMarket Performance Summary & Weekly Top Stock Performers List - baoquankhu1.vn
Illumina To Webcast Upcoming Investor Conference - marketscreener.com
Illumina, Inc. (ILMN) Stock Analysis: Evaluating a 16% Upside Potential Amidst Strong Growth Metrics - DirectorsTalk Interviews
Decoding early synaptic failure in Alzheimer’s disease through multiomic analysis - Illumina
Illumina’s AI-Driven Data Vision Is Expanding — Will Multiomics Integration Unlock a Transformational Edge? - Smartkarma
The future of global food security may depend on quality agrigenomics software - Illumina
Illumina Conservation Deal Highlights New Genomics Demand And Valuation Debate - Sahm
How Illumina Inc. stock performs during Fed tightening cyclesDip Buying & Stepwise Entry and Exit Trade Signals - mfd.ru
Illumina (NASDAQ:ILMN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
From sample to insight: Streamlining analysis with the Illumina 5-base solution - Illumina
Illumina completes acquisition of SomaLogic from Standard BioTools - BizWest
Illumina, Inc. $ILMN Stock Holdings Lowered by Rhumbline Advisers - MarketBeat
Krilogy Financial LLC Takes $1.34 Million Position in Illumina, Inc. $ILMN - MarketBeat
Illumina Crash 10% on Earnings: Why the Stock Could Rebound to $185 in 2026 - TIKR.com
Decoding Illumina Inc (ILMN): A Strategic SWOT Insight - GuruFocus
How Illumina Inc. stock trades before earningsGap Down & Weekly High Return Stock Opportunities - mfd.ru
Illumina (ILMN) is a Top-Ranked Growth Stock: Should You Buy? - Nasdaq
Illumina Q4 Earnings & Revenues Top Estimates, Stock Dips - Nasdaq
Illumina's (NASDAQ:ILMN) Profits Appear To Have Quality Issues - Yahoo Finance
5 Insightful Analyst Questions From Illumina's Q4 Earnings Call - Finviz
5 Insightful Analyst Questions From Illumina’s Q4 Earnings Call - Yahoo Finance
Insider Buying: Scott Gottlieb Acquires Shares of Illumina Inc (ILMN) - GuruFocus
Scott Gottlieb Buys 200 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
Ngs Oncology Market Is Going to Boom | Illumina • Roche • Thermo Fisher Scientific - openPR.com
Simplifying library prep: All in a day’s work for Louise Fraser - Illumina
0.38%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):